GlassScriptPhysician profile
Jacob Taylor
NPI 1568966885
$1,725.75
in general payments reported to CMS, 2019-2025
29 companies · $409 in 2025
The $409 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $570 · 2022: $435 · 2023: $137 · 2024: $175 · 2025: $409.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $721.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $721.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Davol INC. | $311.50 | 2022-2025 | Phasix Mesh |
| Jazz Pharmaceuticals INC. | $146.49 | 2021-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $130.50 | 2021-2022 | |
| Paratek Pharmaceuticals, INC. | $114.50 | 2023-2025 | Nuzyra |
| Si-Bone, INC. | $107.64 | 2021 | |
| Intuitive Surgical, INC. | $95.34 | 2022 | |
| Redhill Biopharma INC. | $94.15 | 2021-2022 | |
| Regeneron Healthcare Solutions, INC. | $88.91 | 2021-2025 | Dupixent |
| Mylan Specialty L.P. | $83.39 | 2021 | |
| Kerecis Limited | $73.64 | 2023-2024 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Harmony Biosciences LLC | $45.64 | 2021-2025 | |
| Intra-Sana Laboratories | $42.83 | 2022 | |
| Solventum Corporation | $40.50 | 2024-2025 | Activ.A.C., Promogran Prisma, V.A.C. Veraflo |
| Braintree Laboratories, INC. | $37.61 | 2024 | Sutab, Suflave |
| Grifols USA, LLC | $34.84 | 2021-2023 | Prolastin-C Liquid |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $32.26 | 2025 | Apligraf |
| Mallinckrodt Hospital Products INC. | $28.60 | 2022 | |
| Medtronic, INC. | $25.07 | 2024 | Signia |
| Philips North America LLC | $20.94 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $19.93 | 2025 | |
| Melinta Therapeutics, LLC | $19.82 | 2025 | Orbactiv, Kimyrsa, Rezzayo |
| Ethicon US, LLC | $18.83 | 2025 | Echelon; Endopath, Echelon Flex |
| Avanos Medical | $18.14 | 2024 | On-Q* Pump and Accessories |
| Phathom Pharmaceuticals, INC. | $17.78 | 2025 | Voquezna |
| Pulmonx Corporation | $17.08 | 2023 | Pulmonx Chartis Tablet Console, Zephyr Delivery Catheter, Zephyr Endobronchial Valve |
| Convatec INC. | $16.26 | 2022 | |
| Abbvie INC. | $14.84 | 2025 | |
| Sunovion Pharmaceuticals INC. | $14.39 | 2021 | |
| Smith+Nephew, INC. | $14.33 | 2024 | Renasys Go V2 Home |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jacob Taylor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.